Dianthus Therapeutics | MGTA - Loan Capital


Dianthus Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Akebia Therapeutics USD 24.75M 11.64M Jun/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Avita Medical AUD 42.24M 1.25M Dec/2024
Celltrion KRW 411.27B 998.23M Mar/2026
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 50M 30M Mar/2026
IQVIA Holdings USD 13.7B 284M Jun/2026
Kangmei Pharma CNY 68.57M 9.87M Mar/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Moderna USD 597M 6M Jun/2026
Organigram Holdings CAD 60.76M 1.77M Mar/2026
Organon & Co USD 8.48B 74M Jun/2026
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 32.13M 1.04M Jun/2026
Qiagen NV USD 1.63B 19.45M Jun/2026
Revvity USD 2.63B 1.02M Jun/2026
Sartorius EUR 3.65B 311.1M Jun/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Tectonic Therapeutic USD 17K 26K Mar/2026
Tilray USD 268.59M 3.82M Sep/2025
Viatris USD 11.61B 801.1M Jun/2026
Xeris Pharmaceuticals USD 188.81M 32.42M Jun/2026
Zealand Pharma A/S 307M 76.14M Mar/2026
Zz Pientze Pharmaceu CNY 172.8M 9.49M Jun/2026